Eli Lilly (LLY) Net Cash Flow (2009 - 2026)

Eli Lilly (LLY) has 18 years of Net Cash Flow data on file, last reported at -$2.1 billion in Q1 2026.

• For the quarter ending Q1 2026, Net Cash Flow fell 568.73% year-over-year to -$2.1 billion; the trailing twelve-month figure through Mar 2026 stood at $1.9 billion (up 147.01% YoY), and the FY2025 full-year result was $3.6 billion, up 386.33% from the prior year.
• Net Cash Flow for Q1 2026 stood at -$2.1 billion, up from -$2.5 billion in the prior quarter.
• Across five years, Net Cash Flow topped out at $6.4 billion in Q3 2025 and bottomed at -$2.5 billion in Q4 2025.
• The 5-year median for Net Cash Flow is -$81.5 million (2024), against an average of $77.7 million.
• The widest annual swing landed in 2023, when Net Cash Flow slumped 16689.47%; it then surged 7933.5% in 2025.
• A 5-year view of Net Cash Flow shows it stood at -$422.2 million in 2022, then jumped by 173.07% to $308.5 million in 2023, then grew by 6.13% to $327.4 million in 2024, then sank by 850.27% to -$2.5 billion in 2025, then rose by 16.42% to -$2.1 billion in 2026.
• The last three Net Cash Flow figures came in at -$2.1 billion (Q1 2026), -$2.5 billion (Q4 2025), and $6.4 billion (Q3 2025), per Business Quant data.

Peer Comparison